Acetaldehyde accumulation suppresses Kupffer cell release of TNF-α and modifies acute hepatic inflammation in rats

Journal of Gastroenterology

Volumn 39, Issue 2, 2004, Pages 140-147

  Nakamura, Yuji ^a,b   Yokoyama, Hirokazu ^a   Higuchi, Susumu ^b   Hara, Sachiko ^b   Kato, Shinzo ^a   Ishii, Hiromasa ^a  

^a KEIO UNIVERSITY   (Japan)

^b KURIHAMA NATIONAL HOSPITAL   (Japan)

Author keywords

Acetaldehyde; Inflammation; Kupffer cells; Lipopolysaccharide; TNF

Indexed keywords

ACETALDEHYDE; ACETIC ACID; ALCOHOL; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE INHIBITOR; CYANAMIDE; CYTOKINE; DISULFIRAM; LIPOPOLYSACCHARIDE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL LIVER DISEASE; ALCOHOL OXIDATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BLOOD ANALYSIS; BLOOD LEVEL; CELL COUNT; CELL ISOLATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DISEASE ASSOCIATION; ENZYME ACTIVITY; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; INHIBITION KINETICS; KUPFFER CELL; MACROPHAGE FUNCTION; MALE; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

ACETALDEHYDE; ANIMALS; BLOTTING, NORTHERN; CELL CULTURE TECHNIQUES; CYANAMIDE; DISULFIRAM; ETHANOL; HEPATITIS, TOXIC; KUPFFER CELLS; LIPOPOLYSACCHARIDES; LIVER; MALE; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1542345454     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-003-1278-5     Document Type: Article

References (29)

1. Muntwyler J, Hennekens CH, Buring JE, Gaziano JM. Mortality and light to moderate alcohol consumption after myocardial infarction. Lancet 1998;352:1882-5.
2. Adachi Y, Bradford BU, Gao W, Bojes HK, Thurman RG. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 1994;20:453-60.
3. Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 1995;108:218-24.
4. Takada A, Takase S, Tsutsumi M. Characteristic features of alcoholic liver disease in Japan: a review. Gastroenterol Jpn 1993;28: 137-48.
5. Weisburger JH. Worldwide prevention of cancer and other chronic diseases based on knowledge of mechanisms. Mutat Res 1998;402:331-7.
6. Harada S, Misawa S, Agarwal DP, Goedde HW. Liver alcohol dehydrogenase and aldehyde dehydrogenase in the Japanese: isozyme variation and its possible role in alcohol intoxication. Am J Hum Genet 1980;32:8-15.
7. Hecht SS, McIntee EJ, Wang M. New DNA adducts of crotonaldehyde and acetaldehyde. Toxicology 2001;166:31-6.
8. Jeong KS, Soh Y, Jeng J, Felder MR, Hardwick JP, Song BJ. Cytochrome P450 2E1 (CYP2E1)-dependent production of a 37-kDa acetaldehyde-protein adduct in the rat liver. Arch Biochem Biophys 2000;384:81-7.
9. Svegliati-Barom G, Baraona E, Rosman AS, Lieber CS. Collagen-acetaldehyde adducts in alcoholic and nonalcoholic liver diseases. Hepatology 1994;20:111-8.
10. Niemela O, Israel Y, Mizoi Y, Fukunaga T, Eriksson CJ. Hemoglobin-acetaldehyde adducts in human volunteers following acute ethanol ingestion. Alcohol Clin Exp Res 1990;14: 838-41.
11. Fleisher JH, Lung CC, Meinke GC, Pinnas JL. Acetaldehydealbumin adduct formation: possible relevance to an immunologic mechanism in alcoholism. Alcohol Alcohol 1988;23:133-41.
12. Smith SL, Jennett RB, Sorrell ME, Tuma DJ. Substoichiometric inhibition of microtubule formation by acetaldehyde-tubulin adducts. Biochem Pharmacol 1992;44:65-72.
13. Nakamura Y, Yokoyama H, Okamura Y, Ohgo H, Fukuda M, Horie Y, et al. Evidence for ethanol oxidation by Kupffer cells. Alcohol Clin Exp Res 1999;23(suppl 4):92S-5S.
14. Maher JJ, Friedman SL. Parenchymal and nonparenchymal cell interactions in the liver. Semin Liver Dis 1993;13:13-20.
15. Iversen OH. The cell kinetics of the inflammatory reaction. Introduction and overview. Curr Top Pathol 1989;79:1-5.
16. van Furth R. Macrophage activity and clinical immunology. Origin and kinetics of mononuclear phagocytes. Ann N Y Acad Sci 1976;278:161-75.
17. Sheila S, Dooley J. Diseases of the liver and biliary system. 10th ed. Oxford: Blackwell Science, 1997.
18. Lindros KO, Jokelainen K, Nanji AA. Acetaldehyde prevents nuclear factor-κB activation and hepatic inflammation in ethanolfed rats. Lab Investig 1999;79:799-806.
19. Nakamura Y, Yokoyama H, Kato S, Ishii H. Major role of cytochrome P450 2E1 in ethanol oxidation by Kupffer cells. Res Commun Alcohol Subst Abuse 1999;20:15-25.
20. Eriksson CJ, Atkinson N, Petersen DR, Deitrich RA. Blood and liver acetaldehyde concentrations during ethanol oxidation in C57 and DBA mice. Biochem Pharmacol 1984;33:2213-6.
21. Fox ES, Cantrell CH, Leingang KA. Inhibition of Kupffer cell inflammatory response by acute ethanol: NF-kappa B activation and subsequent cytokine production. Biochem Biophys Res Commun 1996;225:134-40.
22. Szabo G. Consequences of alcohol consumption on host defence. Alcohol Alcohol 1999;34:830-41.
23. Jokelainen K, Thomas P, Lindros K, Nanji AA. Acetaldehyde inhibits NF-κB activation through IκBα preservation in rat Kupffer cells. Biochem Biophys Res Commun 1998;253:834-6.
24. Drummer S, Hauser WE Jr, Remington JS. Antabuse-like effect of beta-lactam antibiotics. N Engl J Med 1980;303: 1417-8.
25. Little RG 2nd, Petersen DR. Effect of tolbutamide and chlorpropamide on acetaldehyde metabolism in two inbred strains of mice. Toxicol Appl Pharmacol 1985;80:206-14.
26. Winter D, Stanescu C, Sauvard S. The effect of metronidazol on the toxicity of ethanol. Biochem Pharmacol 1969;18:1246-8.
27. Koivisto T, Salaspuro M. Effects of acetaldehyde on brush border enzyme activities in human colon adenocarcinoma cell line Caco-2. Alcohol Clin Exp Res 1997;21:1599-605.
28. Brecher AS, Yang MP. Acetaldehyde inhibits chymotrypsin and serum anti-chymotrypsin activity. J Investig Med 1998;46:146-52.
29. Zhang Z, Cork J, Ye P, Lei D, Schwarzenberger PO, Summer WR, et al. Inhibition of TNF-α processing and TACE-mediated ectodomain shedding by ethanol. J Leukoc Biol 2000;67:856-62.